REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.
Also called NCT07216170
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Registry
-
NCT07216170
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07216170. Allocation not applicable; no masking; primary purpose treatment. Start 2026-12 (anticipated); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke
- Acronym
- REVIVE
- Condition
- Acute Ischemic Stroke
- Intervention (Device)
- SOFIA Flow 88 Aspiration Catheter
- Lead sponsor
- Microvention-Terumo, Inc.
- Collaborator
- Bright Research Partners
Record details
- Record id
cardio:ct-nct07216170- Content hash
7dfa66472ff944955683dd8813cf4d3a6f820ca9afb32d48976f9fd6ebb0d35b